Risk stratification using stress echocardiography: Incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of Bayesian pretest probabilities for coronary artery disease

Objectives: We sought to evaluate the risk stratification ability and incremental prognostic value of stress echocardiography over historic, clinical, and stress electrocardiographic (ECG) variables, over a wide spectrum of bayesian pretest probabilities of coronary artery disease (CAD). Background. Stress echocardiography is an established technique for the diagnosis of CAD. However, data on incremental prognostic value of stress echocardiography over historic, clinical, and stress ECG variables in patients with known or suggested CAD is limited. Methods: We evaluated 3259 patients (60 13 years, 48% men) undergoing stress echocardiography. Patients were grouped into low (< 15%), intermediate (15-85%), and high (>85%) pretest CAD likelihood subgroups using standard software. The historical, clinical, stress ECG, and stress echocardiographic variables were recorded for the entire cohort. Follow-up (2.7 +/- 1.1 years) for confirmed myocardial infarction (n = 66) and cardiac death (n = 105) was obtained. Results: For the entire cohort, an ischemic stress echocardiography study confers a 5.0 times higher cardiac event rate than the normal stress echocardiography group (4.0% vs 0.80/o/y, P <.0001). Furthermore, Cox proportional hazard regression model showed incremental prognostic value of stress echocardiography variables over historic, clinical, and stress ECG variables across all pretest probability subgroups (global chi(2) increased from 5.1 to 8.5 to 20.1 in the low pretest group, P =.44 and P =.01; from 20.9 to 28.2 to 116 in the intermediate pretest group, P =.47 and P <.0001; and from 17.5 to 36.6 to 61.4 in the high pretest group, P <.0001 for both groups). Conclusions: A normal stress echocardiography portends a benign prognosis (<1% event rate/y) in all pretest probability subgroups and even in patients with high pretest probability and yields incremental prognostic value over historic, clinical, and stress ECG variables across all pretest probability subgroups. The best incremental value is, however, in the intermediate pretest probability subgroup.